Investor Optimism Abounds Bluebird Bio, Inc. (NASDAQ:BLUE) But Growth Is Lacking

Simply Wall St12/13 21:07

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

Benzinga12/13 08:50

Reported Sunday, Bluebird Bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024

Benzinga12/09 15:48

Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or...

Benzinga12/08 04:30

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga12/06 05:05

Bluebird Bio Announces 1-for-20 Reverse Stock Split

Businesswire12/05 05:05